Literature DB >> 32421351

Pleural Disease Management: Manometry-guided Thoracentesis, Optimal Drainage Regimen of Indwelling Pleural Catheters, and Talc Poudrage versus Slurry for Malignant Pleural Effusion.

Andrea Mytinger1, Trevor Taylor1, Evgeni Gershman1, Samira Shojaee1.   

Abstract

Mesh:

Substances:

Year:  2020        PMID: 32421351      PMCID: PMC7397784          DOI: 10.1164/rccm.202003-0599RR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  17 in total

1.  Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions.

Authors:  A H Diacon; C Wyser; C T Bolliger; M Tamm; M Pless; A P Perruchoud; M Solèr
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

2.  Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes.

Authors:  Pyng Lee
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

Review 3.  Malignant pleural effusion: from bench to bedside.

Authors:  Ioannis Psallidas; Ioannis Kalomenidis; Jose M Porcel; Bruce W Robinson; Georgios T Stathopoulos
Journal:  Eur Respir Rev       Date:  2016-06

4.  Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.

Authors:  Rajesh Thomas; Edward T H Fysh; Nicola A Smith; Pyng Lee; Benjamin C H Kwan; Elaine Yap; Fiona C Horwood; Francesco Piccolo; David C L Lam; Luke A Garske; Ranjan Shrestha; Christopher Kosky; Catherine A Read; Kevin Murray; Y C Gary Lee
Journal:  JAMA       Date:  2017-11-21       Impact factor: 56.272

5.  Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial.

Authors:  Robert J Lentz; Andrew D Lerner; Jasleen K Pannu; Christopher M Merrick; Lance Roller; Charla Walston; Sarah Valenti; Tracey Goddard; Heidi Chen; John T Huggins; Otis B Rickman; Lonny Yarmus; Ioannis Psallidas; Najib M Rahman; Richard W Light; Fabien Maldonado
Journal:  Lancet Respir Med       Date:  2019-02-13       Impact factor: 30.700

6.  Impact of pleural manometry on the development of chest discomfort during thoracentesis: a symptom-based study.

Authors:  Jasleen Pannu; Zachary S DePew; John J Mullon; Craig E Daniels; Clinton E Hagen; Fabien Maldonado
Journal:  J Bronchology Interv Pulmonol       Date:  2014-10

7.  Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.

Authors:  Sanjeevan Muruganandan; Maree Azzopardi; Deirdre B Fitzgerald; Ranjan Shrestha; Benjamin C H Kwan; David C L Lam; Christian C De Chaneet; Muhammad Redzwan S Rashid Ali; Elaine Yap; Claire L Tobin; Luke A Garske; Phan T Nguyen; Christopher Stanley; Natalia D Popowicz; Christopher Kosky; Rajesh Thomas; Catherine A Read; Charley A Budgeon; David Feller-Kopman; Nick A Maskell; Kevin Murray; Y C Gary Lee
Journal:  Lancet Respir Med       Date:  2018-07-20       Impact factor: 30.700

8.  Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions.

Authors:  David E Ost; Jiangong Niu; Hui Zhao; Horiana B Grosu; Sharon H Giordano
Journal:  Chest       Date:  2017-08-31       Impact factor: 9.410

9.  Large-volume thoracentesis and the risk of reexpansion pulmonary edema.

Authors:  David Feller-Kopman; David Berkowitz; Phillip Boiselle; Armin Ernst
Journal:  Ann Thorac Surg       Date:  2007-11       Impact factor: 4.330

Review 10.  Contemporary best practice in the management of malignant pleural effusion.

Authors:  Coenraad F N Koegelenberg; Jane A Shaw; Elvis M Irusen; Y C Gary Lee
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.